CGON vs BIIB: Which Stock is Better?

Side-by-side comparison of Cg Oncology Inc and Biogen Inc in 2026

Comparison Updated:

CGON

Cg Oncology Inc

$68.68

BIIB

Biogen Inc

$184.38

Key Metrics Comparison

MetricCGONBIIBWinner
Market Cap$5.90B$27.57BBIIB
P/E RatioN/A21.40BIIB
EPS (TTM)$N/A$8.78BIIB
Revenue Growth4.1%-0.1%CGON
Gross Margin-2902.2%78.9%BIIB

Analyze CGON

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CGON or BIIB a better investment?

Comparing CGON and BIIB: Cg Oncology Inc has a market cap of $5.90B while Biogen Inc has $27.57B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CGON and BIIB?

CGON (Cg Oncology Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CGON or BIIB?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CGON or BIIB?

CGON has higher revenue growth at 4.1% vs -0.1% for BIIB.

Which company is more profitable: CGON or BIIB?

Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -2902.2% for CGON.

Which is the larger company: CGON or BIIB?

Biogen Inc (BIIB) is larger with a market cap of $27.57B compared to $5.90B for CGON.

Should I buy CGON or BIIB in 2026?

Both CGON and BIIB have investment merit. CGON trades at $68.68 while BIIB trades at $184.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CGON and BIIB stock?

Key differences: Market Cap ($5.90B vs $27.57B), P/E Ratio (N/A vs 21.4x), Revenue Growth (4.1% vs -0.1%), Gross Margin (-2902.2% vs 78.9%).

Popular Stock Comparisons